国际标准期刊号: 2167-065X

临床药理学与生物药剂学

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • Genamics 期刊搜索
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Formulation and evaluation of drug phospholipid complex based self-Nano emulsifying drug delivery system (dpc-snedds) of bcs class iii drug: lisinopril

Md Shahnawaz Alam* ¸ Dr. Anoop Kumar¸ Pankaj pal

Poor bioavailability of a drug can be regarded as a consequence from two predominant factors if impaired permeation of drug across enterocytes and its poor aqueous solubility.This article intended to focus Drug Phospholipid Complexation (DPC) and its incorporation into SNEDDS as a dual delivery platform to improve drug bioavailability. Phospholipid complexation of drugs could bring out modulation in the intestinal permeability through inhibition of enzymatic activity via membrane perturbation of SNEDDS components, inhibition of membrane bound p-glycoprotein and efflux transporters. DPC components may allow switching over to lymphatic transport through chylomicron formation or enhancing the uptake of phospholipid vesicles through cellular internalization. It also addresses the challenges in the designing of DPC for highly soluble as well as poorly water-soluble drugs, methods of preparation and characterization. Various strategies to incorporate DPC into SNEDDS based systems and how it facilitates the drug characteristics through nanonization or micellization drug molecules are described. The organoleptic property of Lisinopril was determined by molecular weight, structure, melting point, FTIR and DSC. In the development of LPC- SNEDDS, Soy lecithin, Tween-80 and Polyethylene Glycol (PEG) 600 was selected based on the solubility and miscibility study. LPC-SNEDDS was prepared by simple mixing method and characterized. Optimized liquid LPC-SNEDDS formulation showed 232 nm droplet size, 0.438 PDI, -1.11 mV Zeta potential and 0.664 mS/cm electro conductivity. The Ex-vivo permeability of the optimized LPC-SNEDDS formulation showed 100 % drug release within 1hours and the Lisinopril suspension showed 54.9 % in 1 hours. The results obtained from studies in Wistar rats revealed distinct augmentation in permeability and absorption potential of the optimized formulations.